Emergent BioSolutions Reports Financial Results For Second Quarter 2021

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. CDNS
2. AVGO
3. SPY
4. META
5. JBLU
6. ANT
7. SSD
8. ARTV
9. AAPL
10. INTC

Go back to Emergent BioSolutions Reports Financial Results For Second Quarter 2021

Emergent BioSolutions (EBS) Misses Q2 EPS by $1.21

July 29, 2021 4:17 PM EDT

Emergent BioSolutions (NYSE: EBS) reported Q2 EPS of $0.33, $1.21 worse than the analyst estimate of $1.54. Revenue for the quarter came in at $397.5 million versus the consensus estimate of $398.93 million.

GUIDANCE:

Emergent BioSolutions sees Q3 2021 revenue of $1700-1900 billion, versus the consensus of... More